NO922202L - Nye proteiner med onkostatin m aktivitet og fremgangsmaatefor fremstilling av disse - Google Patents

Nye proteiner med onkostatin m aktivitet og fremgangsmaatefor fremstilling av disse

Info

Publication number
NO922202L
NO922202L NO92922202A NO922202A NO922202L NO 922202 L NO922202 L NO 922202L NO 92922202 A NO92922202 A NO 92922202A NO 922202 A NO922202 A NO 922202A NO 922202 L NO922202 L NO 922202L
Authority
NO
Norway
Prior art keywords
oncostatin
mutants
activity
procedure
preparation
Prior art date
Application number
NO92922202A
Other languages
English (en)
Other versions
NO922202D0 (no
NO301769B1 (no
Inventor
Peter S Linsley
Jeffrey C Kallestad
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NO922202L publication Critical patent/NO922202L/no
Publication of NO922202D0 publication Critical patent/NO922202D0/no
Publication of NO301769B1 publication Critical patent/NO301769B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
NO922202A 1989-12-08 1992-06-04 Fremgangsmåte for fremstilling av onkostatin M mutant NO301769B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44775989A 1989-12-08 1989-12-08
US62386790A 1990-12-03 1990-12-03
PCT/US1990/007227 WO1991009057A1 (en) 1989-12-08 1990-12-07 Novel proteins with oncostatin m activity and process for their preparation

Publications (3)

Publication Number Publication Date
NO922202L true NO922202L (no) 1992-06-04
NO922202D0 NO922202D0 (no) 1992-06-04
NO301769B1 NO301769B1 (no) 1997-12-08

Family

ID=27035080

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922202A NO301769B1 (no) 1989-12-08 1992-06-04 Fremgangsmåte for fremstilling av onkostatin M mutant

Country Status (17)

Country Link
EP (1) EP0504291B1 (no)
JP (1) JPH05504134A (no)
KR (1) KR920703636A (no)
CN (1) CN1055389A (no)
AT (1) ATE168117T1 (no)
AU (1) AU651330B2 (no)
CA (1) CA2070171A1 (no)
DE (1) DE69032471T2 (no)
DK (1) DK0504291T3 (no)
ES (1) ES2120958T3 (no)
FI (1) FI104424B (no)
GR (1) GR3027654T3 (no)
IL (1) IL96593A0 (no)
NO (1) NO301769B1 (no)
NZ (1) NZ236382A (no)
PT (1) PT96134B (no)
WO (1) WO1991009057A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
CA2178256A1 (en) * 1995-06-06 1996-12-07 Christopher H. Clegg Oncostatin m induced hematopoiesis
GB9806530D0 (en) 1998-03-26 1998-05-27 Glaxo Group Ltd Inflammatory mediator
US20120308517A1 (en) 2010-02-09 2012-12-06 Digna Biotech, S.L. Compositions for the treatment of infectious and tumoural diseases

Also Published As

Publication number Publication date
KR920703636A (ko) 1992-12-18
ES2120958T3 (es) 1998-11-16
EP0504291A1 (en) 1992-09-23
FI922612A (fi) 1992-06-05
FI922612A0 (fi) 1992-06-05
AU7036191A (en) 1991-07-18
NZ236382A (en) 1992-08-26
PT96134A (pt) 1991-09-30
FI104424B (fi) 2000-01-31
CA2070171A1 (en) 1991-06-09
EP0504291A4 (en) 1992-10-28
AU651330B2 (en) 1994-07-21
EP0504291B1 (en) 1998-07-08
GR3027654T3 (en) 1998-11-30
NO922202D0 (no) 1992-06-04
DE69032471D1 (de) 1998-08-13
NO301769B1 (no) 1997-12-08
CN1055389A (zh) 1991-10-16
IL96593A0 (en) 1991-09-16
ATE168117T1 (de) 1998-07-15
WO1991009057A1 (en) 1991-06-27
DK0504291T3 (da) 1998-11-30
DE69032471T2 (de) 1999-03-04
PT96134B (pt) 1998-04-30
JPH05504134A (ja) 1993-07-01

Similar Documents

Publication Publication Date Title
Chen et al. Further studies on the thymocyte stimulating factor
GR3017535T3 (en) Live vaccines.
NZ330060A (en) method of culturing hematopoietic cells in a growth media containing human interleukin-3 mutant fusion protein
ATE247708T1 (de) Verfahren zur regulierung der metabolischen stabilität von proteinen
DK509286D0 (da) Neovaskulariseringsinhibitor og fremgangsmaade til fremstilling derafsamt anvendelse deraf
DK312387A (da) Humane tumor tnf polypeptidmutanter, deres fremstilling og dna, kodende disse
PT83972A (de) Gm-csf-protein seine derivate herstellung solcher proteine und ihre verwendung
DK1200561T3 (da) Rekombinant stabil celleklon, dens fremstilling og anvendelse
DK91389A (da) Kallikreiner, deres fremstilling og laegemidler indeholdende polypeptiderne
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
BR9506272B8 (pt) PROTEÍNA MUTANTE ISOLADA E PURIFICADA Hin47 DE Haemophilus influenzae, MOLÉCULA QUIMÉRICA, MOLÉCULA DE ÁCIDO NUCLÉICO, PLASMÍDEO RECOMBINANTE, CÉLULA E. coli TRANSFORMADA, COMPOSIÇÃO IMUNOGÊNICA, PROCESSO PARA DETERMINAR A PRESENÇA DE ANTICORPOS, ESPECIFICAMENTE REATIVOS COM A PROTEÍNA Hin47 NUMA AMOSTRA, PROCESSO PARA DETERMINAR A PRESENÇA DE PROTEÍNA Hin47 NUMA AMOSTRA E KIT DE DIAGNÓSTICO PARA DETERMINAR A PRESENÇA DE ANTICORPOS NUMA AMOSTRA ESPECIFICAMENTE REATIVA COM A PROTEÍNA Hin47.
NO922202D0 (no) Nye proteiner med onkostatin m aktivitet og fremgangsmaatefor fremstilling av disse
DK0757994T3 (da) TCF-mutanter
DK0667872T3 (da) Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6
JPS6480298A (en) Production of human proapolipoprotein a-i-like protein
DE3850933D1 (de) Anticoagulatorisches Protein PP4-X, seine Herstellung und Verwendung.
ATE192191T1 (de) Methode zur verbesserten herstellung einer produzierende zellinie durch verwendung eines fusionsprotokolls
IT1259473B (it) Miscela per coltura batterica in campioni biologici e procedimento per ottenerla